BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 7002355)

  • 1. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled trial of aspirin in cerebral ischemia.
    Fields WS; Lemak NA; Frankowski RF; Hardy RJ; Bigelow RH
    Circulation; 1980 Dec; 62(6 Pt 2):V90-6. PubMed ID: 7002356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
    Gent M; Barnett HJ; Sackett DL; Taylor DW
    Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controversy on platelet-inhibiting drugs].
    Oelz O
    Schweiz Med Wochenschr; 1985 May; 115(20):703-7. PubMed ID: 3892659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.
    Cairns JA; Gent M; Singer J; Finnie KJ; Froggatt GM; Holder DA; Jablonsky G; Kostuk WJ; Melendez LJ; Myers MG
    N Engl J Med; 1985 Nov; 313(22):1369-75. PubMed ID: 3903504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
    Robertson JT; Dugdale M; Salky N; Robinson H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for the management of transient ischemic attacks.
    Sandok BA; Furlan AJ; Whisnant JP; Sundt TM
    Mayo Clin Proc; 1978 Oct; 53(10):665-74. PubMed ID: 362079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
    Canadian Cooperative Study Group
    N Engl J Med; 1978 Jul; 299(2):53-9. PubMed ID: 351394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversy in the interpretation of clinical trials.
    Armitage P
    Ann Neurol; 1979 Jun; 5(6):601-2. PubMed ID: 382980
    [No Abstract]   [Full Text] [Related]  

  • 14. Does aspirin prevent stroke?
    Mitchell JR
    Practitioner; 1979 Nov; 223(1337):668-72. PubMed ID: 394138
    [No Abstract]   [Full Text] [Related]  

  • 15. The Canadian cooperative study of platelet suppressant therapy in threatened stroke.
    Gent M
    Thromb Haemost; 1979 Feb; 41(1):163-70. PubMed ID: 483230
    [No Abstract]   [Full Text] [Related]  

  • 16. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
    Barnett HJ; Gent M; Sackett DL; Taylor DW
    Ann Neurol; 1979 Jun; 5(6):599-601. PubMed ID: 382979
    [No Abstract]   [Full Text] [Related]  

  • 17. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
    Stachenko SJ; Bravo G; Côté R; Boucher J; Battista RN
    Fam Pract Res J; 1991 Jun; 11(2):179-91. PubMed ID: 1829313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.